Global and Japan Anthrax Vaccines Market Insights, Forecast to 2027

Global and Japan Anthrax Vaccines Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Anthrax Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Anthrax Vaccines Market Size Growth Rate by Type
1.2.2 Live Vaccines
1.2.3 Cell free PA Vaccines
1.3 Market by Application
1.3.1 Global Anthrax Vaccines Market Size Growth Rate by Application
1.3.2 Human Use
1.3.3 Animal Use
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anthrax Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Anthrax Vaccines Revenue 2016-2027
2.1.2 Global Anthrax Vaccines Sales 2016-2027
2.2 Global Anthrax Vaccines, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Anthrax Vaccines Historical Market Size by Region (2016-2021)
2.3.1 Global Anthrax Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Anthrax Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Anthrax Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Anthrax Vaccines Sales Forecast by Region (2022-2027)
2.4.2 Global Anthrax Vaccines Revenue Forecast by Region (2022-2027)
3 Global Anthrax Vaccines Competitor Landscape by Players
3.1 Global Top Anthrax Vaccines Manufacturers by Sales
3.1.1 Global Anthrax Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Anthrax Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Anthrax Vaccines Manufacturers by Revenue
3.2.1 Key Anthrax Vaccines Manufacturers Covered: Ranking by Revenue
3.2.2 Global Anthrax Vaccines Revenue by Manufacturers (2016-2021)
3.2.3 Global Anthrax Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Anthrax Vaccines Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Anthrax Vaccines Revenue in 2020
3.2.6 Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Anthrax Vaccines Price by Manufacturers
3.4 Global Anthrax Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Anthrax Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anthrax Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Anthrax Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Anthrax Vaccines Market Size by Type (2016-2021)
4.1.1 Global Anthrax Vaccines Sales by Type (2016-2021)
4.1.2 Global Anthrax Vaccines Revenue by Type (2016-2021)
4.1.3 Anthrax Vaccines Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Anthrax Vaccines Market Size Forecast by Type (2022-2027)
4.2.1 Global Anthrax Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Anthrax Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Anthrax Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Anthrax Vaccines Market Size by Application (2016-2021)
5.1.1 Global Anthrax Vaccines Sales by Application (2016-2021)
5.1.2 Global Anthrax Vaccines Revenue by Application (2016-2021)
5.1.3 Anthrax Vaccines Price by Application (2016-2021)
5.2 Anthrax Vaccines Market Size Forecast by Application (2022-2027)
5.2.1 Global Anthrax Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Anthrax Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Anthrax Vaccines Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Anthrax Vaccines Market Size YoY Growth 2016-2027
6.1.1 Japan Anthrax Vaccines Sales YoY Growth 2016-2027
6.1.2 Japan Anthrax Vaccines Revenue YoY Growth 2016-2027
6.1.3 Japan Anthrax Vaccines Market Share in Global Market 2016-2027
6.2 Japan Anthrax Vaccines Market Size by Players (International and Local Players)
6.2.1 Japan Top Anthrax Vaccines Players by Sales (2016-2021)
6.2.2 Japan Top Anthrax Vaccines Players by Revenue (2016-2021)
6.3 Japan Anthrax Vaccines Historic Market Review by Type (2016-2021)
6.3.1 Japan Anthrax Vaccines Sales Market Share by Type (2016-2021)
6.3.2 Japan Anthrax Vaccines Revenue Market Share by Type (2016-2021)
6.3.3 Japan Anthrax Vaccines Price by Type (2016-2021)
6.4 Japan Anthrax Vaccines Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Anthrax Vaccines Sales Forecast by Type (2022-2027)
6.4.2 Japan Anthrax Vaccines Revenue Forecast by Type (2022-2027)
6.4.3 Japan Anthrax Vaccines Price Forecast by Type (2022-2027)
6.5 Japan Anthrax Vaccines Historic Market Review by Application (2016-2021)
6.5.1 Japan Anthrax Vaccines Sales Market Share by Application (2016-2021)
6.5.2 Japan Anthrax Vaccines Revenue Market Share by Application (2016-2021)
6.5.3 Japan Anthrax Vaccines Price by Application (2016-2021)
6.6 Japan Anthrax Vaccines Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Anthrax Vaccines Sales Forecast by Application (2022-2027)
6.6.2 Japan Anthrax Vaccines Revenue Forecast by Application (2022-2027)
6.6.3 Japan Anthrax Vaccines Price Forecast by Application (2022-2027)
7 North America
7.1 North America Anthrax Vaccines Market Size YoY Growth 2016-2027
7.2 North America Anthrax Vaccines Market Facts & Figures by Country
7.2.1 North America Anthrax Vaccines Sales by Country (2016-2021)
7.2.2 North America Anthrax Vaccines Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Anthrax Vaccines Market Size YoY Growth 2016-2027
8.2 Asia Pacific Anthrax Vaccines Market Facts & Figures by Region
8.2.1 Asia Pacific Anthrax Vaccines Sales by Region (2016-2021)
8.2.2 Asia Pacific Anthrax Vaccines Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Anthrax Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Anthrax Vaccines Market Facts & Figures by Country
9.2.1 Europe Anthrax Vaccines Sales by Country (2016-2021)
9.2.2 Europe Anthrax Vaccines Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Anthrax Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Anthrax Vaccines Market Facts & Figures by Country
10.2.1 Latin America Anthrax Vaccines Sales by Country (2016-2021)
10.2.2 Latin America Anthrax Vaccines Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Anthrax Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Anthrax Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Anthrax Vaccines Sales by Country (2016-2021)
11.2.2 Middle East and Africa Anthrax Vaccines Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Emergent BioSolutions
12.1.1 Emergent BioSolutions Corporation Information
12.1.2 Emergent BioSolutions Description and Business Overview
12.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Emergent BioSolutions Anthrax Vaccines Products Offered
12.1.5 Emergent BioSolutions Recent Development
12.2 Merial
12.2.1 Merial Corporation Information
12.2.2 Merial Description and Business Overview
12.2.3 Merial Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merial Anthrax Vaccines Products Offered
12.2.5 Merial Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Description and Business Overview
12.3.3 Merck Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Anthrax Vaccines Products Offered
12.3.5 Merck Recent Development
12.4 Zoetis
12.4.1 Zoetis Corporation Information
12.4.2 Zoetis Description and Business Overview
12.4.3 Zoetis Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Zoetis Anthrax Vaccines Products Offered
12.4.5 Zoetis Recent Development
12.5 Bayer Sanidad Animal
12.5.1 Bayer Sanidad Animal Corporation Information
12.5.2 Bayer Sanidad Animal Description and Business Overview
12.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer Sanidad Animal Anthrax Vaccines Products Offered
12.5.5 Bayer Sanidad Animal Recent Development
12.6 Colorado Serum
12.6.1 Colorado Serum Corporation Information
12.6.2 Colorado Serum Description and Business Overview
12.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Colorado Serum Anthrax Vaccines Products Offered
12.6.5 Colorado Serum Recent Development
12.7 PharmAthene
12.7.1 PharmAthene Corporation Information
12.7.2 PharmAthene Description and Business Overview
12.7.3 PharmAthene Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 PharmAthene Anthrax Vaccines Products Offered
12.7.5 PharmAthene Recent Development
12.8 Tiankang
12.8.1 Tiankang Corporation Information
12.8.2 Tiankang Description and Business Overview
12.8.3 Tiankang Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Tiankang Anthrax Vaccines Products Offered
12.8.5 Tiankang Recent Development
12.9 Biogénesis-Bago
12.9.1 Biogénesis-Bago Corporation Information
12.9.2 Biogénesis-Bago Description and Business Overview
12.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Biogénesis-Bago Anthrax Vaccines Products Offered
12.9.5 Biogénesis-Bago Recent Development
12.10 CAVAC
12.10.1 CAVAC Corporation Information
12.10.2 CAVAC Description and Business Overview
12.10.3 CAVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CAVAC Anthrax Vaccines Products Offered
12.10.5 CAVAC Recent Development
12.11 Emergent BioSolutions
12.11.1 Emergent BioSolutions Corporation Information
12.11.2 Emergent BioSolutions Description and Business Overview
12.11.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Emergent BioSolutions Anthrax Vaccines Products Offered
12.11.5 Emergent BioSolutions Recent Development
12.12 Agrovet
12.12.1 Agrovet Corporation Information
12.12.2 Agrovet Description and Business Overview
12.12.3 Agrovet Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Agrovet Products Offered
12.12.5 Agrovet Recent Development
12.13 Vecol
12.13.1 Vecol Corporation Information
12.13.2 Vecol Description and Business Overview
12.13.3 Vecol Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Vecol Products Offered
12.13.5 Vecol Recent Development
12.14 CVCRI
12.14.1 CVCRI Corporation Information
12.14.2 CVCRI Description and Business Overview
12.14.3 CVCRI Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 CVCRI Products Offered
12.14.5 CVCRI Recent Development
12.15 IVPM
12.15.1 IVPM Corporation Information
12.15.2 IVPM Description and Business Overview
12.15.3 IVPM Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.15.4 IVPM Products Offered
12.15.5 IVPM Recent Development
12.16 Prondil
12.16.1 Prondil Corporation Information
12.16.2 Prondil Description and Business Overview
12.16.3 Prondil Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Prondil Products Offered
12.16.5 Prondil Recent Development
12.17 CDV
12.17.1 CDV Corporation Information
12.17.2 CDV Description and Business Overview
12.17.3 CDV Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.17.4 CDV Products Offered
12.17.5 CDV Recent Development
12.18 Indian Immunologicals
12.18.1 Indian Immunologicals Corporation Information
12.18.2 Indian Immunologicals Description and Business Overview
12.18.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Indian Immunologicals Products Offered
12.18.5 Indian Immunologicals Recent Development
12.19 Botswana Vaccine Institute
12.19.1 Botswana Vaccine Institute Corporation Information
12.19.2 Botswana Vaccine Institute Description and Business Overview
12.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Botswana Vaccine Institute Products Offered
12.19.5 Botswana Vaccine Institute Recent Development
12.20 Ceva Santé Animale
12.20.1 Ceva Santé Animale Corporation Information
12.20.2 Ceva Santé Animale Description and Business Overview
12.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Ceva Santé Animale Products Offered
12.20.5 Ceva Santé Animale Recent Development
12.21 Intervac
12.21.1 Intervac Corporation Information
12.21.2 Intervac Description and Business Overview
12.21.3 Intervac Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Intervac Products Offered
12.21.5 Intervac Recent Development
12.22 JOVAC
12.22.1 JOVAC Corporation Information
12.22.2 JOVAC Description and Business Overview
12.22.3 JOVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.22.4 JOVAC Products Offered
12.22.5 JOVAC Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Anthrax Vaccines Industry Trends
13.2 Anthrax Vaccines Market Drivers
13.3 Anthrax Vaccines Market Challenges
13.4 Anthrax Vaccines Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anthrax Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Anthrax Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Cell free PA Vaccines
Table 4. Global Anthrax Vaccines Market Size Growth Rate by Application (2021-2027) & (M Doses)
Table 5. Global Anthrax Vaccines Market Size by Region (M Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Anthrax Vaccines Sales by Regions (2016-2021) & (M Doses)
Table 7. Global Anthrax Vaccines Sales Market Share by Regions (2016-2021)
Table 8. Global Anthrax Vaccines Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Anthrax Vaccines Sales Forecast by Region (2022-2027) & (M Doses)
Table 10. Global Anthrax Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Anthrax Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Anthrax Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Anthrax Vaccines Sales by Manufacturers (2016-2021) (M Doses)
Table 14. Global Anthrax Vaccines Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Anthrax Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 16. Anthrax Vaccines Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Anthrax Vaccines Revenue Share by Manufacturers (2016-2021)
Table 18. Global Anthrax Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Anthrax Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anthrax Vaccines as of 2020)
Table 20. Key Manufacturers Anthrax Vaccines Price (2016-2021) (USD/Dose)
Table 21. Anthrax Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Anthrax Vaccines Product Type
Table 23. Date of International Manufacturers Enter into Anthrax Vaccines Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Anthrax Vaccines Sales by Type (2016-2021) (M Doses)
Table 26. Global Anthrax Vaccines Sales Share by Type (2016-2021)
Table 27. Global Anthrax Vaccines Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Anthrax Vaccines Revenue Share by Type (2016-2021)
Table 29. Anthrax Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/Dose)
Table 30. Global Anthrax Vaccines Sales Forecast by Type (2022-2027) & (M Doses)
Table 31. Global Anthrax Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Anthrax Vaccines Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Anthrax Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Anthrax Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Dose)
Table 35. Global Anthrax Vaccines Sales by Application (2016-2021) (M Doses)
Table 36. Global Anthrax Vaccines Sales Share by Application (2016-2021)
Table 37. Global Anthrax Vaccines Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Anthrax Vaccines Revenue Share by Application (2016-2021)
Table 39. Anthrax Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/Dose)
Table 40. Global Anthrax Vaccines Sales Forecast by Application (2022-2027) & (M Doses)
Table 41. Global Anthrax Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Anthrax Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Anthrax Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Anthrax Vaccines Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Dose)
Table 45. Japan Anthrax Vaccines Sales (M Doses) of Key Companies (2016-2021)
Table 46. Japan Anthrax Vaccines Sales Share by Company (2016-2021)
Table 47. Japan Anthrax Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Anthrax Vaccines Revenue Share by Company (2016-2021)
Table 49. Japan Anthrax Vaccines Sales (M Doses) by Type (2016-2021)
Table 50. Japan Anthrax Vaccines Sales Share by Type (2016-2021)
Table 51. Japan Anthrax Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Anthrax Vaccines Price (USD/Dose) by Type (2016-2021)
Table 53. Japan Anthrax Vaccines Sales (M Doses) by Type (2022-2027)
Table 54. Japan Anthrax Vaccines Sales Share by Type (2022-2027)
Table 55. Japan Anthrax Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Anthrax Vaccines Revenue Share by Type (2022-2027)
Table 57. Japan Anthrax Vaccines Price (USD/Dose) by Type (2022-2027)
Table 58. Japan Anthrax Vaccines Sales (M Doses) by Application (2016-2021)
Table 59. Japan Anthrax Vaccines Sales Share by Application (2016-2021)
Table 60. Japan Anthrax Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Anthrax Vaccines Price (USD/Dose) by Application (2016-2021)
Table 62. Japan Anthrax Vaccines Sales (M Doses) by Application (2022-2027)
Table 63. Japan Anthrax Vaccines Sales Share by Application (2022-2027)
Table 64. Japan Anthrax Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Anthrax Vaccines Revenue Share by Application (2022-2027)
Table 66. Japan Anthrax Vaccines Price (USD/Dose) by Application (2022-2027)
Table 67. North America Anthrax Vaccines Sales by Country (2016-2021) & (M Doses)
Table 68. North America Anthrax Vaccines Sales Market Share by Country (2016-2021)
Table 69. North America Anthrax Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Anthrax Vaccines Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Anthrax Vaccines Sales by Region (2016-2021) & (M Doses)
Table 72. Asia Pacific Anthrax Vaccines Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Anthrax Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Anthrax Vaccines Revenue Market Share by Region (2016-2021)
Table 75. Europe Anthrax Vaccines Sales by Country (2016-2021) & (M Doses)
Table 76. Europe Anthrax Vaccines Sales Market Share by Country (2016-2021)
Table 77. Europe Anthrax Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Anthrax Vaccines Revenue Market Share by Country (2016-2021)
Table 79. Latin America Anthrax Vaccines Sales by Country (2016-2021) & (M Doses)
Table 80. Latin America Anthrax Vaccines Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Anthrax Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Anthrax Vaccines Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Anthrax Vaccines Sales by Country (2016-2021) & (M Doses)
Table 84. Middle East and Africa Anthrax Vaccines Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Anthrax Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Anthrax Vaccines Revenue Market Share by Country (2016-2021)
Table 87. Emergent BioSolutions Corporation Information
Table 88. Emergent BioSolutions Description and Business Overview
Table 89. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 90. Emergent BioSolutions Anthrax Vaccines Product
Table 91. Emergent BioSolutions Recent Development
Table 92. Merial Corporation Information
Table 93. Merial Description and Business Overview
Table 94. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 95. Merial Product
Table 96. Merial Recent Development
Table 97. Merck Corporation Information
Table 98. Merck Description and Business Overview
Table 99. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 100. Merck Product
Table 101. Merck Recent Development
Table 102. Zoetis Corporation Information
Table 103. Zoetis Description and Business Overview
Table 104. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 105. Zoetis Product
Table 106. Zoetis Recent Development
Table 107. Bayer Sanidad Animal Corporation Information
Table 108. Bayer Sanidad Animal Description and Business Overview
Table 109. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 110. Bayer Sanidad Animal Product
Table 111. Bayer Sanidad Animal Recent Development
Table 112. Colorado Serum Corporation Information
Table 113. Colorado Serum Description and Business Overview
Table 114. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 115. Colorado Serum Product
Table 116. Colorado Serum Recent Development
Table 117. PharmAthene Corporation Information
Table 118. PharmAthene Description and Business Overview
Table 119. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 120. PharmAthene Product
Table 121. PharmAthene Recent Development
Table 122. Tiankang Corporation Information
Table 123. Tiankang Description and Business Overview
Table 124. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 125. Tiankang Product
Table 126. Tiankang Recent Development
Table 127. Biogénesis-Bago Corporation Information
Table 128. Biogénesis-Bago Description and Business Overview
Table 129. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 130. Biogénesis-Bago Product
Table 131. Biogénesis-Bago Recent Development
Table 132. CAVAC Corporation Information
Table 133. CAVAC Description and Business Overview
Table 134. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 135. CAVAC Product
Table 136. CAVAC Recent Development
Table 137. Rosenbusch Corporation Information
Table 138. Rosenbusch Description and Business Overview
Table 139. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 140. Rosenbusch Product
Table 141. Rosenbusch Recent Development
Table 142. Agrovet Corporation Information
Table 143. Agrovet Description and Business Overview
Table 144. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 145. Agrovet Product
Table 146. Agrovet Recent Development
Table 147. Vecol Corporation Information
Table 148. Vecol Description and Business Overview
Table 149. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 150. Vecol Product
Table 151. Vecol Recent Development
Table 152. CVCRI Corporation Information
Table 153. CVCRI Description and Business Overview
Table 154. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 155. CVCRI Product
Table 156. CVCRI Recent Development
Table 157. IVPM Corporation Information
Table 158. IVPM Description and Business Overview
Table 159. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 160. IVPM Product
Table 161. IVPM Recent Development
Table 162. Prondil Corporation Information
Table 163. Prondil Description and Business Overview
Table 164. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 165. Prondil Product
Table 166. Prondil Recent Development
Table 167. CDV Corporation Information
Table 168. CDV Description and Business Overview
Table 169. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 170. CDV Product
Table 171. CDV Recent Development
Table 172. Indian Immunologicals Corporation Information
Table 173. Indian Immunologicals Description and Business Overview
Table 174. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 175. Indian Immunologicals Product
Table 176. Indian Immunologicals Recent Development
Table 177. Botswana Vaccine Institute Corporation Information
Table 178. Botswana Vaccine Institute Description and Business Overview
Table 179. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 180. Botswana Vaccine Institute Product
Table 181. Botswana Vaccine Institute Recent Development
Table 182. Ceva Santé Animale Corporation Information
Table 183. Ceva Santé Animale Description and Business Overview
Table 184. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 185. Ceva Santé Animale Product
Table 186. Ceva Santé Animale Recent Development
Table 187. Intervac Corporation Information
Table 188. Intervac Description and Business Overview
Table 189. Intervac Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 190. Intervac Product
Table 191. Intervac Recent Development
Table 192. JOVAC Corporation Information
Table 193. JOVAC Description and Business Overview
Table 194. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 195. JOVAC Product
Table 196. JOVAC Recent Development
Table 197. Anthrax Vaccines Market Trends
Table 198. Anthrax Vaccines Market Drivers
Table 199. Anthrax Vaccines Market Challenges
Table 200. Anthrax Vaccines Market Restraints
Table 201. Anthrax Vaccines Customers List
Table 202. Anthrax Vaccines Distributors List
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Anthrax Vaccines Product Picture
Figure 2. Global Anthrax Vaccines Sales Market Share by Type in 2020 & 2027
Figure 3. Live Vaccines Product Picture
Figure 4. Cell free PA Vaccines Product Picture
Figure 5. Global Anthrax Vaccines Sales Market Share by Application in 2020 & 2027
Figure 6. Human Use
Figure 7. Animal Use
Figure 8. Anthrax Vaccines Report Years Considered
Figure 9. Global Anthrax Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anthrax Vaccines Market Size 2016-2027 (US$ Million)
Figure 11. Global Anthrax Vaccines Sales 2016-2027 (M Doses)
Figure 12. Global Anthrax Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Anthrax Vaccines Sales Market Share by Region (2016-2021)
Figure 14. Global Anthrax Vaccines Sales Market Share by Region in 2020
Figure 15. Global Anthrax Vaccines Revenue Market Share by Region (2016-2021)
Figure 16. Global Anthrax Vaccines Revenue Market Share by Region in 2020
Figure 17. Global Anthrax Vaccines Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Anthrax Vaccines Revenue in 2020
Figure 19. Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Anthrax Vaccines Sales Market Share by Type (2016-2021)
Figure 21. Global Anthrax Vaccines Sales Market Share by Type in 2020
Figure 22. Global Anthrax Vaccines Revenue Market Share by Type (2016-2021)
Figure 23. Global Anthrax Vaccines Revenue Market Share by Type in 2020
Figure 24. Global Anthrax Vaccines Sales Market Share by Application (2016-2021)
Figure 25. Global Anthrax Vaccines Sales Market Share by Application in 2020
Figure 26. Global Anthrax Vaccines Revenue Market Share by Application (2016-2021)
Figure 27. Global Anthrax Vaccines Revenue Market Share by Application in 2020
Figure 28. Japan Anthrax Vaccines Sales Growth Rate 2016-202

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs